Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
- 1 February 1999
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (2), 515-523
- https://doi.org/10.1016/s0002-9440(10)65297-2
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.The Journal of cell biology, 1995
- ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.The Journal of cell biology, 1994
- Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.The Journal of cell biology, 1993
- Mutations of theAPC adenomatous polyposis coli) geneHuman Mutation, 1993
- Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.The Journal of Experimental Medicine, 1992
- The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system.The Journal of cell biology, 1992
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrinThe Journal of cell biology, 1988
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987